AIS Healthcare Announces New Chief Legal & Compliance Officer

AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, is announcing the appointment of Sybil Rajan as Chief Legal Officer and Chief Compliance Officer. In this role, Sybil will lead AIS Healthcare’s Legal and Compliance departments, building upon an already strong foundation to support safe, strategic growth in an increasingly complex regulatory environment.

“We are so thrilled to welcome Sybil,” said Simon Castellanos, AIS Healthcare’s Chief Executive Officer. “Her proven track record of success and process improvement, combined with her commitment to quality of care will be key as we continue to strengthen our legal and compliance team.”

Sybil brings extensive leadership experience in both healthcare and administrative roles. Most recently, she served as General Counsel and Chief Administrative Officer at GenesisCare, an oncology care company, where she led the Legal, People, and Culture departments through a post-bankruptcy turnaround and successful sale. Following this success, she continued to support the organization as an Advisor to the Board of Directors.

“I’m very excited to join AIS and contribute to our shared mission,” said Sybil. “Together we will navigate an ever-changing legal landscape to deliver high-quality, patient-centered care.”

Sybil holds a Juris Doctor from Cornell Law School, a Master of Public Health from The University of Texas Health Science Center at Houston, and a Bachelor of Business Administration in Business Honors and Finance from The University of Texas at Austin.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260429382100/en/